Print Version
Multidrug-Resistant Tuberculosis (MDR TB)
Publication Date:
2012
Country of Origin:
United States
Format:
Information Sheet
Language:
English
Abstract
This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at risk for getting MDR TB. The information sheet also explains how MDR TB can be prevented, TB vaccine, the symptoms of TB disease, and what an individual should do after being exposed to someone with TB.
Publisher:
Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention
Audience(s):
Health Professionals
Topic:
MDR TB
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.